Results 11 to 20 of about 13,355 (171)
Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma [PDF]
Cancers, 2023 Alessandra Pulliero +2 more
exaly +2 more sources
Vaccine: XBackground: While it is well-known that vaccine hesitancy can be vaccine-specific, little is known about how people spontaneously evaluate different vaccines in comparison with one another, or the implications of such comparisons for vaccine attitudes ...
Elena Semino +5 more
doaj +3 more sources
Efficacy of Rubella Vaccination after Co-Inoculation with Rhogam
Viruses, 2023 Congenital rubella syndrome is a constellation of birth defects that can have devastating consequences, impacting approximately 100,000 births worldwide each year. The incidence is much lower in countries that routinely vaccinate their population. In the
Joshua S. Brunton +5 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2023 Combined measles-mumps-rubella (MMR) vaccines produced by GSK (GSK-MMR) and Merck (Merck-MMR) have demonstrated effectiveness and an acceptable safety profile, as documented over decades of post-licensure use in various regions worldwide.
Md Ahsan Habib +4 more
doaj +1 more source
Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England
Vaccines, 2023 Measles, a highly infectious respiratory viral infection associated with severe morbidity and mortality, is preventable when coverage with the highly effective measles, mumps and rubella vaccine (MMR) is ≥95%. Vaccine hesitancy is responsible for measles
Sarah Thompson +3 more
doaj +1 more source
International Journal of Pediatrics & Adolescent Medicine, 2022 Background: Influenza vaccine participation in adolescents is low. Barriers to the influenza vaccine may be shared with the measles-mumps-rubella (MMR) vaccine.
F. Trent Beeninga +4 more
doaj +1 more source
Archives of Disease in Childhood, 2000 Live measles and mumps vaccine viruses are cultured in chick embryo fibroblasts and may contain minute amounts of egg related antigens.1-3 In view of this, there has been a longstanding debate on the safety of these vaccines in children with severe allergic reactions to egg. Initially it was believed that such children could safely receive the vaccine;
R, Lakshman, A, Finn
openaire +2 more sources
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
Molecular Therapy: Oncolytics, 2022 Common vaccines for infectious diseases have been repurposed as cancer immunotherapies. The intratumoral administration of these repurposed vaccines can induce immune cell infiltration into the treated tumor. Here, we have used an approved trivalent live
Manlio Fusciello +10 more
doaj +1 more source
Vaccines, 2022 Cross-protection from previous live attenuated vaccines is proposed to explain the low impact of COVID-19 on children. This study aimed to evaluate the effect of live attenuated MMR vaccines on the risk of being hospitalized for COVID-19 in children.
Epiphane Kolla +5 more
doaj +1 more source
Memorias do Instituto Oswaldo Cruz, 2019 BACKGROUND Field testing required to license the combined measles, mumps, and rubella (MMR) vaccine must take into account the current recommendation of the vaccine in Brazil: first dose at 12 months and second dose at 15 months of age in combination ...
Eliane Matos dos Santos +12 more
doaj +1 more source